Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Hesperadin

Product Specifications

UNSPSC Description

Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM. Hesperadin inhibits the growth of Trypanosoma brucei by blocking nuclear division and cytokinesis. Hesperadin also is a broad-spectrum influenza antiviral[1][2][3].

Target Antigen

Aurora Kinase; Autophagy; Influenza Virus; Parasite

Type

Reference compound

Related Pathways

Anti-infection;Autophagy;Cell Cycle/DNA Damage;Epigenetics

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Hesperadin.html

Purity

98.00

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=C1NC2=CC=C(C=C2/C1=C(NC3=CC=C(C=C3)CN4CCCCC4)\C5=CC=CC=C5)NS(CC)(=O)=O

Molecular Weight

516.65

References & Citations

[1]Neal J, et, al. The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in bloodstream forms. Mol Microbiol. 2009 Apr; 72(2): 442-58.|[2]Wahafu A, et, al. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide. Pathol Res Pract. 2019 Nov; 215(11): 152617.|[3]Hu Y, et, al. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci. 2017 Sep 8;18(9):1929.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-12054/Hesperadin-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-12054/Hesperadin-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

CAS Number

422513-13-1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Phospholipase A2, Secretory, Group XII, Recombinant, Human (PLA2, sPLA2-XII)
MBS636574-01 0.002 mg

Phospholipase A2, Secretory, Group XII, Recombinant, Human (PLA2, sPLA2-XII)

Ask
View Details
Phospholipase A2, Secretory, Group XII, Recombinant, Human (PLA2, sPLA2-XII)
MBS636574-02 0.01 mg

Phospholipase A2, Secretory, Group XII, Recombinant, Human (PLA2, sPLA2-XII)

Ask
View Details
Phospholipase A2, Secretory, Group XII, Recombinant, Human (PLA2, sPLA2-XII)
MBS636574-03 5x 0.01 mg

Phospholipase A2, Secretory, Group XII, Recombinant, Human (PLA2, sPLA2-XII)

Ask
View Details
WSCD2, CT (WSCD2, KIAA0789, WSC domain-containing protein 2) (MaxLight 650)
MBS6363794-01 0.1 mL

WSCD2, CT (WSCD2, KIAA0789, WSC domain-containing protein 2) (MaxLight 650)

Ask
View Details
WSCD2, CT (WSCD2, KIAA0789, WSC domain-containing protein 2) (MaxLight 650)
MBS6363794-02 5x 0.1 mL

WSCD2, CT (WSCD2, KIAA0789, WSC domain-containing protein 2) (MaxLight 650)

Ask
View Details
RASL1 Antibody
C45799-01 50 µL

RASL1 Antibody

Ask
View Details